Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

L-tyrosine

L-Tyrosine · also known as Tyrosine, L-Tyrosine

L-tyrosine is a precursor for synthesizing catecholamine neurotransmitters, and human metabolic markers support this role. However, tyrosine hydroxylation is the main rate-limiting step. There is no guarantee that usual doses increase neurotransmitter release in the brain, and evidence for cognitive improvement under stress is also insufficient.

Typical dose: 500–2000 mg/day, taken in the morning or before demanding mental work. The advantage of taking it on an empty stomach, or 30–45 minutes apart from a protein meal, has not been established.
Absorption and forms: Free L-tyrosine has modest water solubility, but intestinal absorption is good. N-acetyl-L-tyrosine (NALT) is a different compound, and their effective doses and conversion rates are not directly interchangeable. A high-protein meal can affect competitive transport of large neutral amino acids, but the advantage of taking it 30 minutes apart from a protein meal has not been established.

Clinical uses and human evidence

Memory

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Jongkees 2020 · Cogn Affect Behav Neurosci · Randomized crossover trial · n=45 — Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
  2. Thomas 1999 · Pharmacol Biochem Behav · Other human study · n=20 — Tyrosine improves working memory in a multitasking environment

Low mood

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Gelenberg 1990 · J Affect Disord · RCT · n=65 — Tyrosine for depression: a double-blind trial

Mechanisms of action

Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)

★★★★☆Mechanism evidence: grade B

Tyrosine is a precursor for dopamine and noradrenaline synthesis, and human metabolic markers support this role. However, tyrosine hydroxylation is the main rate-limiting step. The doses used in the studies above were typically above 0.5–2 g/day. There is no guarantee that usual doses increase central neurotransmitter release, and evidence for cognitive improvement under stress is also insufficient.

References (2)
  1. Growdon 1982 · Study in 23 people with Parkinson disease: after oral intake of about 100 mg/kg/day, cerebrospinal fluid tyrosine rose, and in the subgroup taking probenecid, homovanillic acid rose
  2. Alonso 1982 · Human study: after a single 100–150 mg/kg dose, urinary catecholamines and their metabolites increased, mainly reflecting peripheral turnover

Safety and drug interactions

People taking monoamine oxidase inhibitor (MAOI) antidepressants must not use it, because it may trigger a hypertensive crisis. People taking levodopa or thyroid hormone should also have interactions checked by a doctor. Use with caution in people with melanoma or hyperthyroidism.

With MAO inhibitors Do not combine

Phenelzine, selegiline, rasagiline, linezolid

Tyrosine is a precursor of noradrenaline, and combining it with MAO inhibitors can cause a hypertensive crisis.

With Levothyroxine Note

Euthyrox, Letrox (levothyroxine)

Tyrosine is a building block of thyroxine, so monitor thyroid function during combined use.

With Levodopa Needs attention

Levodopa/benserazide (Madopar), carbidopa/levodopa (Sinemet)

Tyrosine competes with levodopa for absorption and for transport into the brain, so it may reduce levodopa’s effect. The two should be taken at different times.

Open in the interactive app ›